Clinical Trials Directory

Trials / Unknown

UnknownNCT00186771

Magnetic Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia

Transcranial Magnetic Stimulation Used to Treat Auditory Hallucinations in Schizophrenia

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
St. Joseph's Healthcare Hamilton · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Schizophrenia is a chronic, severe, and disabling brain disease. Auditory hallucinations are the most frequent symptoms with an incident of 50% to 70% in patients. Transcranial Magnetic Stimulation (TMS) can significantly reduce symptoms of schizophrenia. TMS is capable of inducing changes in the electrical activities of the brain in humans. The purpose of this trial is to study the use of TMS to decrease auditory hallucinations in schizophrenia.

Detailed description

We hypothesize that: True treatment with rTMS will have significant decrease in auditory hallucinations versus sham treatment over the temporoparietal cortex. FMRI will highlight areas of activation with auditory hallucinations distinct from the area identified by Hoffman's scalp based method. Cortical inhibition as measured by paired pulse TMS will be increased after true TMS but not sham TMS.

Conditions

Interventions

TypeNameDescription
DEVICEPaired PulseTrue treatment with rTMS over the temporoparietal cortex.
DEVICEPaired PulseSham treatment with rTMS over the temporoparietal cortex.

Timeline

Start date
2004-11-01
Primary completion
2012-01-01
Completion
2015-01-01
First posted
2005-09-16
Last updated
2011-07-28

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT00186771. Inclusion in this directory is not an endorsement.